New approaches to some of the most serious unmet health challenges of our time
An ingredient in a medicinal tea brewed from tree bark by tribal healers on the South Pacific island of Samoa — studied by scientists over the last 25 years — is showing significant promise as a drug lead in the long-sought goal of eliminating the AIDS virus from its sanctuaries in the body and thus eradicating the disease, a scientist said here today.
Speaking at the 246th National Meeting & Exhibition of the American Chemical Society (ACS), Paul A. Wender, Ph.D., described efficient new ways of making prostratin and related leads, as well as other drug candidates first discovered in sea creatures, that appear even more effective for AIDS and have applications for Alzheimer’s disease and cancer.
In his presentation, Wender focused on fundamentally new approaches to some of the most serious unmet health challenges of our time. He is with Stanford University. They include the eradication of AIDS, developing medicines that stop the progression of Alzheimer’s disease and treating resistant cancer — the major cause of chemotherapy failure for most cancers. Almost 7,000 presentations on new molecular discoveries in science and other topics are on the agenda for the meeting of the world’s largest scientific society, which continues through Thursday in the Indiana Convention Center and downtown hotels.
Wender leads a scientific team at Stanford University that first developed a way to make the tea ingredient, prostratin, in large amounts from readily available ingredients. He described how that initial synthesis broke down a major barrier to probing prostratin’s antiviral effects. Until then, scientists had to extract prostratin from the bark of the Samoan mamala tree, and only tiny and variable amounts were so obtained. Samoa is where another scientist, Paul Cox, in 1987 heard a native healer praise mamala bark tea as a remedy for viral hepatitis. It led scientists at the National Cancer Institute to analyze the bark and identify prostratin as a key ingredient. Wender’s synthesis of prostratin opened the door to research on the substance and enabled his team to change prostratin’s architecture.
“We now have made synthetic variants of prostratin, called analogs, that are 100 times more potent than the natural product,” Wender said. “That’s part of the basis for our approach to advancing potentially transformative treatments for AIDS, Alzheimer’s disease and resistant cancer. The mamala tree did not start making prostratin millions of years ago to treat a disease that appeared in the 20th century. The same is true for other substances that occur naturally in plants and animals. But we now have the tools to read nature’s library and use the lessons learned there to design, make and study new molecules that address unmet medical needs. This “function-oriented” approach seeks to identify useful parts of molecules and then, based on this knowledge, to design new and more readily synthesized molecules that work better or work in totally new ways. This is a well-validated strategy, perhaps best exemplified by the emergence of modern aviation from knowledge of how birds fly.”
Those new versions of prostratin show promise in laboratory tests for both preventing HIV from infecting human cells and awakening dormant HIV viruses that are hiding inside human latently infected cells. Latent HIV cell reservoirs are untouchable by today’s antiviral medicines. Antiviral medicines reduce active virus levels in patients’ blood and keep patients healthy. But when patients stop the medication, the hibernating HIV in reservoirs awakens to resupply active virus. Prostratin flushes HIV out of its cellular sanctuaries so that antiviral drugs can attack and hopefully eradicate the HIV from the body. In essence, if one wants to eliminate a weed, one needs to get rid of its roots.
Wender’s group used those same “function-oriented” approaches in the design and synthesis of analogs of bryostatin, a substance that occurs naturally in sea creatures called bryozoans.
“Bryostatin has shown great promise in laboratory experiments as the basis for development of potentially transformative medicines for cancer, Alzheimer’s disease and the eradication of HIV/AIDS,” Wender said. “However, its limited supply from natural sources has slowed research, and as with prostratin, it was not evolved in nature for modern therapeutic use. We have overcome both the supply and performance barriers by designing simpler and thus more readily synthesized analogs of bryostatin — over 100 of them so far. When tested in various assays related to HIV/AIDS eradication, these analogs are up to 1,000-fold more potent in flushing HIV out of its hiding places than prostratin. Much needs to be done, but we are on a promising trajectory.”
The Latest on: Transformative medicines
- Trial of Labstep at MRC Unit The Gambia at LSHTM on December 16, 2018 at 9:26 am
Labstep, a transformative research platform, is pleased to announce the institute-wide trial of their cloud-based technology at Medical Research Council Unit The Gambia at the London School of Hygiene ... […]
- Nature is a rich source of medicine – if we can protect it on December 16, 2018 at 2:28 am
With every habitat that falls to the chainsaw or disappears under the plough or concrete, we impoverish nature and deprive ourselves of potential medicines ... despite the promise of a potentially tra... […]
- The Medicines Company Prices $150 Million of Convertible Notes on December 13, 2018 at 5:43 pm
... Company The Medicines Company is a biopharmaceutical company driven by an overriding purpose – to save lives, alleviate suffering and contribute to the economics of healthcare. The Company’s goal ... […]
- Jeff Jonker Joins Ambys Medicines as President and CEO on December 13, 2018 at 3:30 am
Ambys Medicines, a biotechnology company focused on discovering ... organ transplant is often the only option for patients holds the potential to be truly transformational.” “Since the formation of th... […]
- Empowering patients is more transformational than you thought (or feared) on December 11, 2018 at 9:25 pm
SRI is a leading Developer, Manufacturer & Supplier of Innovative Portable Imaging Equipment. We offer Lightweight, Agile, Easy to Maneuver Portable X-Ray Systems ideal for maneuvering in tight spaces ... […]
- The medicine of the mind on December 10, 2018 at 11:39 pm
“Based on my own personal experience, of course, I think music can be transformative. It can provide the kind ... reducing the use of several psychoactive medications and improving the quality of life ... […]
- Report: University Hospital needs 'transformational leader' on December 10, 2018 at 10:51 am
According to the report, in the five years since University Hospital separated from the former University of Medicine and Dentistry ... The need for a transformational leader focused on creating a vis... […]
- Exclusive: Orchard CEO Touts Transformative Power of Gene Therapy Following ASH Data Presentation on December 7, 2018 at 9:56 am
The word transformative is not used lightly by Orchard Therapeutics Chief Executive Officer Mark Rothera. He has seen the lives of children born with rare autoimmune diseases changed dramatically thro... […]
- Faster diagnosis from 'transformational' gene project on December 5, 2018 at 9:20 am
Genomics England described the project as "transformational in what it means to society ... improved prevention of illness and more targeted medicines. Sir John Chisholm, chair of Genomics England, sa... […]
- Will Personalized Medicine Help Cure Alzheimer’s? on December 4, 2018 at 9:05 am
S., and nearly 6 million Americans of all ages are afflicted with the disease – which is the sixth-leading cause of death in this country, according to the Alzheimer's Association But we have entered ... […]
via Google News and Bing News